WHY IT MATTERS: If India’s human trials produce strong safety and efficacy data, it could accelerate regulatory acceptance of medicinal cannabis across South and Southeast Asia, potentially expanding patient access in regions where options are currently very limited. CLINICAL OVERVIEW: India’s launch of human clinical trials for medicinal cannabis represents a significant regulatory and scientific shift for a country with historically strict drug policies. These trials will generate controlled safety and efficacy data across specific medical conditions, helping to establish evidence-based frameworks for potential therapeutic use.
Munchies phenomenon: WSU study looks into benefits of cannabis use and hunger – KIRO 7
️ The science behind the munchies is more important than you think. New research from WSU is exploring how THC activates cannabinoid receptors in the brain to stimulate appetite, even when the body isn’t hungry. Here’s why this matters clinically: Patients with cancer, HIV, and chronic illness often struggle with dangerous appetite loss Understanding the endocannabinoid system helps us dose more precisely ️ Not everyone wants appetite stimulation, so knowing the mechanism helps us manage side effects too This research bridges the gap between patient experience and clinical evidence Better science = better care at the bedside The “munchies” aren’t just a punchline. For many patients, appetite stimulation is the reason they turned to cannabis in the first place. Drop a if cannabis has helped you or someone you know with appetite issues. New WSU research explains how THC triggers appetite at the brain level, validating what cannabis patients have known for years. Better science means better dosing.
Ohio Issues Recall on Some THC Gummies
Arizona is trying to set fair limits for cannabis-impaired driving, but the science is tricky—THC stays in your system long after the effects wear off, so testing positive doesn’t necessarily mean you’re impaired. Ohio regulators have issued a recall on certain THC gummies due to quality or safety concerns in the state’s regulated cannabis market. The recall underscores the importance of robust product testing and consumer protection in legal cannabis markets.
Hemp Beverage Companies Face Existential Threat Under 0.4mg THC Container Limit
The new federal THC limit of 0.4mg per container would make the low-dose THC seltzers and beverages many people enjoy as alcohol alternatives completely illegal. The Nov 2026 rule caps final products at 0.4mg total THC per container. A typical ‘low-strength’ THC seltzer contains 2-10mg per can—5-25x over the limit.